Mast Group Ltd
Andrew Farish is an experienced IT professional with a strong background in IT infrastructure management and support. Currently serving as an IT Infrastructure Engineer at Mast Group Ltd since April 2022, Andrew provides 3rd line IT support and ensures system maintenance and updates. Previously, Andrew worked as an Infrastructure Analyst at Hill Dickinson LLP, focusing on operational IT infrastructure development and vulnerability resolution, alongside experience at Inprova Group as both an IT Infrastructure Engineer and a 1st Line HelpDesk Technician, where responsibilities included user support, server management, and project assistance. Andrew's career began at the Walton Centre NHS Foundation Trust as a Junior IT Desktop Support Engineer, followed by roles in software support and network auditing. Academic achievements include a Bachelor of Science with Honours in Computer Science from Edge Hill University and a Foundation Degree in Information Technology from Knowsley Community College.
This person is not in any teams
This person is not in any offices
Mast Group Ltd
1 followers
Mast Group Ltd is a UK based leading independent European manufacturer and supplier of clinical diagnostic products. Established in Liverpool in 1957, Mast Group has grown into a multinational company exporting globally. The corporate headquarters Mast Group Ltd are based in Bootle and has subsidiary companies in Reinfeld (Mast Diagnostica GmbH) and Amiens, France (Mast Diagnostic). Mast Group were among the first companies to commercialise the antibiotic disc, and continue to work with major pharmaceutical companies worldwide in the development of new and exciting products. Mast Group focuses on the susceptibility, identification and resistance along with offering molecular and immunochemistry solutions for the IVD market. This is achieved through the investment in personnel, R&D and infrastructure, including state of the art manufacturing facilities in Merseyside. This enables Mast Group to provide tools to aid in the diagnosis of clinical disease, from pioneering antibiotic susceptibility testing to novel molecular solutions, Mast Group continues to develop products for the ever changing IVD market, creating solutions to support clinical diagnosis today and into the future.